Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer

from Cancer via ola Kala on Inoreader http://ift.tt/2wMOBc1
via IFTTT